News About: Goverment
Court rejects pharmacists’ suit for drug dispensing fee
A Seoul Administrative court rejected pharmacists’ injunction request to nullify the proposed cut of dispensing fee at pharmacy.
The court ruled Friday that the Notice of the health ministry was legal because the m...
Pharmacy owners urged to consider pricing option
Starting July 21, 48 over-the-counter (OTC) drugs were allowed to be sold outside pharmacies, such as at supermarkets and 24-hour convenience stores.
But for a while at least, consumers will find things hit or miss...
Opposition party cautious in revision of OTC related bill
The Ministry of Health and Welfare is considering submitting a bill for the revision at the forthcoming regular session of the National Assembly in September to allow the sale of non-prescription drugs at places other...
48 OTC drugs are unavailable at supermarkets
Despite the government’s announcement Wednesday that 48 over-the-counter (OTC) drugs would be available at retail outlets other than pharmacies from Thursday, they were not on the shelves of most convenience stores.
...
Multinational firms opposing new drug pricing policy
The government’s controversial policies to cut drug pricing have been criticized by multinational drug manufacturer here as “rationale-lacking ones.”
The Korean Research-based Pharmaceutical Industry Association (K...
Renowned OTC medicines to be available at supermarkets
Forty-eight health products previously requiring prescription will be available at supermarkets and 24-hour convenience stores nationwide sooner or later, the Ministry of Health and Welfare said Tuesday.
In a brief...
KFDA seeking to reclassify 17 prescription drugs
The Korea Food and Drug Administration’s attempt to permit sales of prescription drugs without prescription was crushed Tuesday as representatives of pharmacists and doctors failed to reach an agreement.
Instead, t...
Medication bill for kidney cancer patients will go down
The drug costs that individuals will have to shoulder for treatment of advanced renal cancer will go down thanks to the recent agreement between the National Health Insurance Corp. (NHIC) and Novartis Korea.
The in...
Health insurance to cover Afinitor
The negotiation ended Friday after a compromise was reached between the National Health Insurance Corp. and Novartis Korea on the insurance price of Afinitor (everolimus), a cancer drug to treat patients with subepend...
KFDA to classify medicines without prejudices
The subcommittee meeting of the Central Pharmaceutical Affairs Council will be held on July 19 under the supervision of the Korea Food and Drug Administration.
The medicine classification committee will make a deci...
